[Percutaneous radiofrequency ablation -- clinical indications and results].
Percutaneous interstitial tumor ablation therapy is a relatively new and steadily growing field within interventional radiology. Radiofrequency ablation (RFA) became one of the most accepted techniques among hyperthermal ablation procedures, presumably due to its superior relation between probe diameter and efficacy. The first part of this review provided an overview of the underlying principles, technical background and application techniques. This second part describes the indications, techniques and results of clinical RFA applied to primary and secondary liver tumors as well as experiences with extrahepatic RFA applied to kidney, bone and lung, together with a discussion of the current literature.
Tacke
J
J
Klinik für Radiologische Diagnostik, Universitätsklinikum Aachen. tacke@rad.rwth-aachen.de
D006528:Carcinoma, Hepatocellular / Q000628:therapy; D006801:Humans; D006979:Hyperthermia, Induced / Q000295:instrumentation*; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D008279:Magnetic Resonance Imaging; D009369:Neoplasms / Q000175:diagnosis / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome